CRA COVID-19 Response Webinar Series

Now more than ever, rheumatologists require timely information regarding the management of COVID-19 in order to work through this global pandemic.  The CRA COVID-19 Response Webinar Series has been developed to provide health care providers within the rheumatology community additional educational resources.

Upcoming Webinars

Managing Immunomodulating Therapies and Immunocompromised Patients During the COVID-19 Pandemic

Date: Monday, June 7, 2021
Time: 7:00 – 8:00 pm ET
Where: Zoom Webinar
Cost:

  • Complimentary for CRA & AHPA members as well as invited guests
  • $25* for non-members
    * Plus applicable taxes; purchases are non-refundable.

An on-demand recording of the webinar will also be available to registrants unable to attend live.

Presenter: Dr. Jinoos Yazdany is Chief of the Division of Rheumatology at San Francisco General Hospital (SFGH) and the Alice Betts Endowed Professor of Medicine at UCSF. She is an epidemiologist who studies the outcomes of rheumatic diseases. In 2020, she co-founded the COVID-19 Global Rheumatology Alliance.

Moderator: Dr. Diane Lacaille

Session Overview
In this session, we will review information collected by the COVID-19 Global Rheumatology Alliance to help guide rheumatology clinicians in assessing and treating patients with rheumatologic disease. We will review the management of COVID-19 in immunosuppressed patients as well as the use of immunomodulatory drugs for COVID-19.

Learning Objectives
At the end of this session, participants will be able to:

  1. identify high level data generated by the COVID-19 Global Rheumatology Alliance
  2. discuss the management of immunocompromised patients during the COVID-19 pandemic
  3. review the use of immunomodulating drugs to treat COVID-19

CanMEDS Roles

  1. Medical Expert
  2. Collaborator
  3. Leader
  4. Scholar
Register Now

On-demand Webinars for CRA members